Publication | Closed Access

Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs

Tumor BiologyOncologyNrf2/are PathwayMedicineOncogenic AgentCell DeathTherapeutic DrugsAnti-cancer AgentNegative RegulationPharmacologyCell BiologyLung CancerCancer Research